证券代码：301285 证券简称：鸿日达 公告编号：2025-079 鸿日达科技股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 特别提示： 1、本次股东大会无否决议案的情形； 2、本次股东大会不涉及变更前次股东大会决议。 一、会议召开和出席情况 （一）会议召开情况 1、现场会议时间：2025 年 12 月 5 日（星期五）13:30。 3、现场会议召开地点：江苏省昆山市玉山镇青淞路 89 号鸿日达科技股份有限公司行 政办公楼一楼大会议室。 4、会议召开方式：采用现场表决与网络投票相结合的表决方式。 5、会议召集人：公司董事会。 6、会议主持人：董事长王玉田先生。 7、本次会议的召集、召开、表决程序符合有关法律法规及《公司章程》等相关规定。 （二）会议出席情况 1、股东出席的总体情况 通过现场和网络投票的股东 43 人，代表股份 128,363,892 股，占公司有表决权股份总 数的 62.2057%。其中：通过现场投票的股东 4 人，代表股份 128,040,192 股，占公司有表 决权股份总数的 62.0 ...

证券代码：301285 证券简称：鸿日达 公告编号：2025-083 鸿日达科技股份有限公司 关于召开 2025 年第三次临时股东会的通知 6、会议的股权登记日：2025 年 12 月 15 日 7、出席对象： 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：2025 年第三次临时股东会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所创业板 股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号—创业板上市公司规范运 作》等法律、行政法规、部门规章、规范性文件及《公司章程》的有关规定。 4、会议时间： （1）现场会议时间：2025 年 12 月 22 日 13:30 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2025 年 12 月 22 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投票系统投 票的具体时间为 2025 年 12 月 22 日 9:15 至 15:00 的任意时间。 5、会议的 ...

国浩律师（北京）事务所 关于 鸿日达科技股份有限公司 2025 年第二次临时股东大会 之 法律意见书 北京市朝阳区东三环北路 38 号泰康金融大厦 9 层 邮编：100026 9/F, Taikang Financial Tower, 38 North Road East Third Ring, Chaoyang District, Beijing 100026, China 电话/Tel: (+86)(10) 6589 0699 传真/Fax: (+86)(10) 6517 6800 网址/Website: www.grandall.com.cn 国浩律师（北京）事务所 法律意见书 国浩律师（北京）事务所 关于鸿日达科技股份有限公司 2025 年第二次临时股东大会之 一、本次股东大会的召集、召开程序 1 国浩律师（北京）事务所 法律意见书 法律意见书 国浩京证字[2025]第0649号 致：鸿日达科技股份有限公司 国浩律师（北京）事务所（以下简称"本所"）接受鸿日达科技股份有限公 司（以下简称"公司"）的委托，指派本所律师出席并见证了公司 2025 年 12 月 5 日召开的 2025 年第二次临时股东大会 ...

证券代码：301285 证券简称：鸿日达 公告编号：2025-081 鸿日达科技股份有限公司 本议案已经公司独立董事专门会议、审计委员会事前审议通过。保荐机构对本事项出具 了核查意见。 本议案尚需提交公司股东会审议。 表决结果：同意 5 票，反对 0 票，弃权 0 票。 具体内容详见公司同日披露于巨潮资讯网（www.cninfo.com.cn）的《关于变更部分募投 项目的公告》。 第二届董事会第十九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 一、董事会会议召开情况 鸿日达科技股份有限公司（以下简称"鸿日达"或"公司"）第二届董事会第十九次会 议通知于 2025 年 12 月 2 日以电话、邮件的方式送达全体董事，于 2025 年 12 月 5 日在公司 行政办公楼一楼大会议室以现场表决方式召开。本次会议由公司董事长王玉田主持，会议应 出席董事 5 人，实际出席董事 5 人，全体高级管理人员列席本次会议。会议的召集、召开符 合《中华人民共和国公司法》等法律法规和公司章程的有关规定，会议形成的决议合法有效。 二、董事会会议审议情况 1、审议通过 ...

证券代码：301285 证券简称：鸿日达 公告编号：2025-078 鸿日达科技股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回 并继续进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 鸿日达科技股份有限公司（以下简称"公司"）于 2025 年 8 月 22 日召开第二届董 事会第十六次会议，审议通过了《关于使用部分闲置募集资金进行现金管理的议案》， 同意在不影响募集资金投资项目建设和公司正常经营的前提下，公司及子公司使用不超 过人民币 2.9 亿元的闲置募集资金进行现金管理，使用期限自前次募集资金现金管理的 授权到期之日起 12 个月内有效，即 2025 年 11 月 3 日至 2026 年 11 月 2 日。在上述额 度的有效期内，资金可滚动使用，同时授权公司董事长在上述额度和期限范围内行使投 资决策权并签署相关文件，公司财务部门具体办理相关事宜。具体内容详见公司 2025 年 8 月 26 日披露于巨潮资讯网（www.cninfo.com.cn）的《关于使用部分闲置募集资金 进行现金管理的公告》（公告编号：2025-060 ...

证券代码：301285 证券简称：鸿日达 公告编号：2025-077 公司与上述银行不存在关联关系。 鸿日达科技股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回 并继续进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 鸿日达科技股份有限公司（以下简称"公司"）于 2025 年 8 月 22 日召开第二届董 事会第十六次会议，审议通过了《关于使用部分闲置募集资金进行现金管理的议案》， 同意在不影响募集资金投资项目建设和公司正常经营的前提下，公司及子公司使用不超 过人民币 2.9 亿元的闲置募集资金进行现金管理，使用期限自前次募集资金现金管理的 授权到期之日起 12 个月内有效，即 2025 年 11 月 3 日至 2026 年 11 月 2 日。在上述额 度的有效期内，资金可滚动使用，同时授权公司董事长在上述额度和期限范围内行使投 资决策权并签署相关文件，公司财务部门具体办理相关事宜。具体内容详见公司 2025 年 8 月 26 日披露于巨潮资讯网（www.cninfo.com.cn）的《关于使用部分闲置募集资金 进行现金管理的公 ...

Core Viewpoint - As of November 14, a total of 96 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more, indicating strong investor interest in these stocks [1] Group 1: Stocks with Significant Net Buying - The stocks with the longest consecutive net buying days are CITIC Bank and Galaxy Microelectronics, both having seen net buying for 13 consecutive trading days [1] - Other notable stocks with significant net buying days include Xinke Mobile, Mingchen Health, Hongrida, Xianggang Technology, Lianrui New Materials, Hualan Biological Engineering, Sunshine Nuohuo, and Zhongguang Optical [1]

Group 1 - The stock price of Hongri Da increased by 2.28%, reaching 57.35 yuan per share, marking a new high [1] - The total market capitalization of the company surpassed 11.852 billion yuan [1] - The trading volume amounted to 29.2919 million yuan [1]

Group 1 - Longjian Co., Ltd. won a bid for a highway maintenance project in Heilongjiang with a contract value of 483 million yuan, accounting for 2.64% of the company's expected revenue for 2024 [1] - Transsion Holdings plans to issue H-shares and list on the main board of the Hong Kong Stock Exchange [1] - Good Home's controlling shareholder intends to reduce its stake by up to 2.7%, equivalent to no more than 39.4468 million shares [1][2] Group 2 - Xinhua Insurance reported a cumulative premium income of 181.973 billion yuan from January to October, representing a year-on-year growth of 17% [2][4] - Zhejiang Jiaokao is part of a consortium that plans to bid for a new urbanization project with an estimated total investment of 11.103 billion yuan [4] Group 3 - Changchun High-tech received approval for clinical trials of a vaccine for adolescents and adults [6] - XinNuoWei's application for the listing of Pertuzumab injection has been accepted, targeting HER2-positive breast cancer [8] - Dash Smart won a bid for an intelligent project at the new Huanggang Port inspection building, valued at 55.056 million yuan, which is 1.74% of its expected revenue for 2024 [8] Group 4 - Electronic City is involved in a lawsuit for debt recovery, with the amount in dispute estimated at 777 million yuan [9] - Haibo Technology signed a strategic cooperation agreement with CATL for a cumulative procurement of no less than 200 GWh of electricity from 2026 to 2028 [10] Group 5 - Renfu Pharmaceutical's HW231019 tablets have entered the second phase of clinical trials for postoperative pain relief [11] - Tonghua Dongbao received a drug registration certificate for Aspart Insulin injection from the Dominican Republic [11] Group 6 - Shaanxi Construction reported winning major projects worth a total of 1.016 billion yuan in October [12] - Fuzhou Environmental Protection plans to change its stock name to "Fuzhou Technology" [12] Group 7 - Panlong Pharmaceutical's gel patch for knee osteoarthritis has received approval for clinical trials [15] - Zhongyida's application for a specific stock issuance has been terminated by the Shanghai Stock Exchange [16] Group 8 - Zhizhong Home's controlling shareholder reduced its holdings of convertible bonds by 905,000 units, accounting for 13.51% of the total issued [19] - Haibo Co., Ltd. plans to establish a subsidiary with an investment of 1 billion yuan for high-end component projects [21] Group 9 - Caina Co. plans to use 57 million yuan of idle funds to purchase structured deposits [23] - Zhendong Pharmaceutical's new drug for acute ischemic stroke has entered the IIa phase of clinical trials [25] Group 10 - Weiman Sealing's overseas subsidiary plans to lease a factory in Saudi Arabia for 5 years at a total rent of approximately 54.039 million yuan [26] - Yiling Pharmaceutical's application for Memantine Hydrochloride has been approved for market entry [28] Group 11 - Dongfang Zhizao plans to acquire 70% of Saifu Machinery for 27.4887 million yuan [30] - JianKai Technology's actual controller intends to transfer 3% of the company's shares through inquiry [31] Group 12 - Rejing Bio plans to repurchase shares worth between 100 million and 200 million yuan [32] - Bangji Technology has decided to terminate a major asset restructuring project due to failure to reach an agreement [34] Group 13 - Huadong Pharmaceutical's application for the marketing license of a new drug has been accepted [36] - Zhonggu Logistics' shareholder plans to reduce its stake by up to 3% [38] Group 14 - Bohui Innovation's subsidiary received approval for a clinical trial of a vaccine for invasive infections [40] - Shannon Chip's shareholder pledged 0.27% of the company's shares for financing [42] Group 15 - Shanghai Petrochemical appointed a new general manager [44] - Jiaojian Co. plans to reduce the holdings of some directors and executives by up to 0.35% [46] Group 16 - Weiting Electric plans to raise no more than 300 million yuan through a private placement [47] - Zhongjin Irradiation plans to invest approximately 200 million yuan in an electronic accelerator manufacturing project [49] Group 17 - Tongxing Technology signed a framework agreement to invest 3.2 billion yuan in a sodium battery project [50] - Hongri Da plans to establish a subsidiary focused on semiconductor packaging [51] Group 18 - Shanghai Kaibao's new drug for acute ischemic stroke has received approval for clinical trials [53] - Yitong Century announced a change in its control structure, becoming a company without a controlling shareholder [55]

分组1 - Midea Group announced a cash dividend distribution plan for the 2025 mid-term A-shares, distributing 5 yuan per 10 shares, totaling 3.448 billion yuan [1] - Huayuan Communication is planning a change in control and will suspend trading of its stock starting November 12, 2025, for up to two trading days [2] - Shangwei New Materials reported a significant stock price increase of 1573.52% from July 9 to November 11, 2025, but its new intelligent robot business is still in the development stage and has not generated revenue [3] 分组2 - Shannon Chip announced that shareholder Shenzhen Xinlianpu pledged 1.27 million shares, accounting for 5.55% of its holdings and 0.27% of the total share capital [4] - Tianji Co., Ltd. reported that its controlling shareholder pledged 39.965 million shares for its own production and operation, representing 64.79% of its holdings and 7.97% of the total share capital [5] - ST Zhengping completed its stock trading situation review and will resume trading on November 12, 2025, with no significant changes in its production and operation [6] 分组3 - Furi Co. reported that its subsidiary Furi New Energy is facing risks of losses despite a 47.78% year-on-year increase in revenue to 168.3981 million yuan for the first three quarters of 2025 [7] - Wentai Technology announced that major shareholders reduced their holdings by 12.4443 million shares, completing the reduction plan [8] 分组4 - Anke Biotech signed a framework agreement for exclusive agency of PA3-17 injection, a CAR-T cell therapy product, in Greater China [9] - Tongxing Technology plans to invest approximately 3.2 billion yuan in a project to produce 100,000 tons of sodium-ion battery cathode materials and 6 GWh of battery cells [10] - Redik plans to establish a joint venture for the development of robotic components, with a registered capital of 100 million yuan [11] 分组5 - Haike New Source signed a strategic cooperation agreement with Kunlun New Materials for the purchase of 596,200 tons of electrolyte solvent over three years [12] - World announced that its diamond micro-drill products for PCB processing are still in the R&D phase and have not generated revenue [13] 分组6 - Xiamen Airport reported a 1.56% year-on-year increase in passenger throughput for October [14] - New City Holdings reported a 7.65% year-on-year increase in total commercial operating revenue for October [15] - Huadong Holdings announced a 0.65% year-on-year decrease in pig sales revenue for October [15] 分组7 - Keykai Technology's controlling shareholder plans to transfer 3% of its shares [15] - Zhongyou Engineering won a joint bid for a project worth approximately 3 billion yuan in Kazakhstan [15] - Weiteng Electric plans to raise no more than 300 million yuan through a private placement for smart manufacturing projects [15]